Tremfya 100 mg/mL single-dose One-Press patient-controlled injector Images
Generic Name: guselkumab
This medication has been identified as Tremfya 100 mg/mL single-dose One-Press patient-controlled injector. It is supplied by Janssen Biotech, Inc.
Tremfya is used in the treatment of Ulcerative Colitis; Psoriatic Arthritis; Crohn's Disease; Plaque Psoriasis; Psoriasis and belongs to the drug class interleukin inhibitors. Tremfya 100 mg/mL single-dose One-Press patient-controlled injector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tremfya
- Generic Name
- guselkumab
- Strength
- 100 mg/mL single-dose One-Press patient-controlled injector
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0640
More about Tremfya (guselkumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (100)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.